Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
soluble LAG-3 protein, human
×
Clear all
Filters
2
NCT04811027
2025-12-11
TACTI-003
Immutep S.A.S.
Phase 2
Completed
171 enrolled
NCT03625323
2024-12-18
TACTI-002
Immutep S.A.S.
Phase 2
Completed
187 enrolled
13 charts